The Netherlands
Sherpa, founded in 2022, is at the forefront of the intersection between healthcare and technology, specifically targeting the management of neurological diseases through remote monitoring. Headquartered in The Netherlands, the company is driven by the slogan: "On a mission to support personalized treatment by remote monitoring of neurological diseases."
Sherpa’s innovative platform leverages digital biomarkers and clinically validated solutions to aid patients and caregivers in the early detection of disease progression, facilitating personalized treatment regimes. This approach not only empowers patients to have greater control over their disease course but also assists clinicians in adhering to monitoring guidelines for neurodegenerative conditions.
Operating in the Health Care and Medical Devices sectors, Sherpa is yet to secure its last investment round. Its commitment to personalized medicine aims to deliver enhanced and more affordable healthcare solutions, positioning the company as a promising candidate for investors seeking opportunities in digital health innovation.
